Form D · Retailing
Sweet Chemistry, Inc.
New York, NY · CIK 0002138153
Offering snapshot reported Jun 25, 2026 · SEC filing
- Reported sold
- $1.6M Offering amount: $1.6M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2026 | Initial | $1,597,995 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588623
Source: Form D, filed Jun 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alec Batis | Promoter |
| Joel Maza | Director, Executive |
| Andrea Nye | Director |
| Kenneth Suslow | Director |
Issuer details
Industry: Retailing (See others in industry)
Address:
455 West 22nd Street 2nd Floor
New York, NY, 10011
Phone: 212-929-4848
New York, NY, 10011
Phone: 212-929-4848